Rapid prediction of human intestinal absorption

Quantitative Structure-Activity Relationships

Volumn 21, Issue 5, 2002, Pages 493-506

  Deretey, Eugen ^a   Feher, Miklos ^a   Schmidt, Jonathan M ^a  

^a Signalgene Inc Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITAL LIBRARIES; HYDROGEN BONDS;

ARC TANGENT FUNCTIONS; CURVE AND SURFACE; DESCRIPTORS; HUMAN INTESTINAL ABSORPTIONS; HYDROGEN BOND ACCEPTORS; NON-LINEAR MODELLING; PASSIVE TRANSPORT; SIGMOIDAL CURVES; SYMMETRICS; TRANSPORT MECHANISM;

FORECASTING;

ACARBOSE; ACEBUTOLOL; ACRIVASTINE; ALPRENOLOL; AMFEBUTAMONE; AMILORIDE; AMRINONE; ATENOLOL; ATROPINE; BETAXOLOL; BROMAZEPAM; BUMETANIDE; CAFFEINE; CARBAMAZEPINE; CEFTRIAXONE; CHLORAMPHENICOL; CHLORPROMAZINE; CICAPROST; CIMETIDINE; CLOFIBRATE; CLONIDINE; COUMARIN; CYMARIN; DIAZEPAM; DISULFIRAM; FLUCONAZOLE; FLUMAZENIL; PARACETAMOL; PHENAZONE; UNINDEXED DRUG;

ARTICLE; CALCULATION; HUMAN; HYDROGEN BOND; INTESTINE ABSORPTION; MODEL; PARTITION COEFFICIENT; PASSIVE TRANSPORT; PREDICTION; PRIORITY JOURNAL;

EID: 0036854258     PISSN: 09318771     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-3838(200211)21:5<493::AID-QSAR493>3.0.CO;2-5     Document Type: Article

References (44)

1. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 23, 3-25 (1997).
2. Palm, K., Stenberg, P., Luthman, K., and Artursson, P., Polar molecular properties predict the intestinal absorption of drugs in humans, Pharm. Res. 14, 568-571 (1997).
3. Sugawara, M., Takeuma, Y., Yamada, H., Kobayashi, M., Iseki, K., and Miyazaki, K., A general approach for the prediction of the intestinal absorption of drugs: Regression analysis using the physicochemical properties and drug-membrane electrostatic interaction, J. Pharm. Sci. 87, 960-966 (1998).
4. Clark, D. E., Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption, J. Pharm. Sci. 88, 807-814 (1999).
5. Raevsky, O. A., Fetisov, V. I., Trepalina, E. P., McFarland, J. W., and Schaper, K.-J., Quantitative estimation of drug absorption in humans for passively transported compounds on the basis of their physico-chemical parameters, Quaint. Struct.-Act. Relat. 19, 366-374 (2000).
6. Zhao, Y. H., Le, J., Abraham, M. H., Hersey, A., Eddershaw, P. J., Luscombe, C. N., Boutina, D., Beck, G., Sherborne, B., Cooper, I., and Platts, J. A., Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors, J. Pharm. Sci. 90, 749-784 (2001).
7. Oprea, T. I., and Gottfries, J., Toward minimalistic modeling of oral drug absorption, J. Mol. Graphics Model. 17, 261-274 (1999).
8. Egan, W. J., Mertz, K. M., and Baldwin, J., Prediction of drug absorption using multivariate statistics, J. Med. Chem. 43, 3867-3877 (2000).
9. Ertl, P., Rohde, B., and Selzer, P., Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties, J. Med. Chem. 43, 3714-3717 (2000).
10. Osterberg, T., and Norinder, U., Prediction of drug transport processes using simple parameters and PLS statistics: The use of ACD/logP and ACD/ChemSketch descriptors, Eur. J. Pharm. Sci. 12, 327-337 (2001).
11. Winiwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., and Karlén, A., Correlation of human jejunal permeability (in Vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach, J. Med. Chem. 41, 4939-4949 (1998).
12. Wessel, M. D., Jurs, P. C., Tolan, J. W., and Muskal, S. M., Prediction of human intestinal absorption of drug compounds from molecular structure, J. Chem. Inf Comput. Sci. 38, 726-735 (1998).
13. Norinder, U., Österberg, T, and Artursson, P., Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics, Eur. J. Pharm. Sci. 8, 49-56 (1999).
14. Norinder, U., and Österberg, T., Theoretical calculation and prediction of drug transport processes using simple parameters and Partial Least Squares projections to latent structures (PLS) statistics. The use of electrotopological state indices, J. Pharm. Sci. 90, 1076-1085 (2001).
15. Stenberg, P., Norinder, U., Luthman, K., and Artursson, P., Experimental and computational screening models for the prediction of intestinal drug absorption, J. Med. Chem. 44, 1927-1937 (2001).
16. Agatonovic-Kustrin, S., Beresford, R., and Yusof, A. P. M., Theoretically-derived molecular descriptors important in human intestinal absorption, J. Pharm. Biomed. Anal. 25, 227-237 (2001).
17. Van der Waterbeemd, H., Smith, D. A., Beaumont, K., and Walker, D. K., Property-based design: Optimization of drug absorption and pharmacokinetics, J. Med. Chem. 44, 1-21 (2001).
18. Stenberg, P., Luthman, K., and Artursson, P., Virtual screening of intestinal drug permeability, J. Contr. Relase 65, 231-243 (2000).
19. Pagliara, A., Reist, M., Geinoz, S., Carrupt, P.-A., and Testa, B., Evaluation and Prediction of Drug Permeation, J. Pharm. Pharmacol. 51, 1339-1357 (1999).
20. Feher, M., Sourial, E., and Schmidt, J. M., A simple model for the prediction of blood-brain partitioning, Int. J. Pharm. 201, 239-247 (2000).
21. Tsuji, A., and Tamai, I., Carrier-mediated intestinal transport of drugs, Pharm. Res. 13, 963-977 (1996).
22. Swaan, P. W., and Tukker, J. J., Molecular determinants of recognition for the intestinal peptide carrier, J. Pharm. Sci. 86, 596-602 (1997).
23. Chong, S., Dando, S. A., Soucek, K. M., and Morrison, R. A., In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system, Pharm. Res. 13, 120-123 (1996).
24. Olinga, P., Merema, M, Hof, I. H., Slooff, M. J. H., Proost, J. H., Meijer, D. K. F., and Groothuis, G. M. M., Characterization of the uptake of rocuronium and digoxin in human hepatocytes: Carrier specificity and comparison with in vivo data, J. Pharm., Exp. Ther 285, 506-510 (1998).
25. Karlsson, J., Ungell, A.-L., Gråsjö, J., and Artursson, P., Paracellular drug transport across intestinal epithelia: Influence of charge and induced water flux, Eur. J. Pharm. Sci. 9, 47-56 (1999).
26. Molecular Operating Environment, Version 2001.02, Chemical Computing Group Inc, Montreal, QC, Canada.
27. S-PLUS Version 4.5, 1998, MathSoft Inc., Seattle, Washington, USA.
28. GNUPLOT, UNIX Version 3.7, 2001.
29. Halgren, T. A., The merck molecular force field. I. Basis, form, scope, parametrization, and performance of MMFF94, J. Comp. Chem. 17, 490-519 (1996).
30. ACD Labs, Version 4.56, 2000, Advance Chemistry Development, Toronto, ON, Canada.
31. Labute, P., MOE LogP(Octanol/Water) Model, unpublished results, implemented in MOE as q logp.svl (1998).
32. Wildman, S. A., and Crippen, G. M., Prediction of Physicochemical Parameters by Atomic Contributions, J. Chem. Inf. Comput. Sci. 39, 868-873 (1999).
33. Labute, P., MOE Molar Refractivity Model, unpublished results, implemented in MOE as q mref.svl (1998).
34. Brasse, C. H., and Bresse, C. P., Understandable Statistics, Concepts and Methods, 5th ed., D. C. Heath&Co., Lexington, Massachusetts, Toronto 1995, p. 351.
35. Manual for the Molecular Operating Environment, version 2001.01, Chemical Computing Group Inc, Montreal, QC, Canada.
36. Du Plessis, J., Pugh, W. J., Judefeind, A., and Hadgraft, J., The effect of hydrogen bonding on diffusion across model membranes: Consideration of the number of H-bonding groups, Eur. J. Pharm. Sci. 13, 135-141 (2001).
37. Abraham, M. H., Scales of hydrogen bonding: Their construction and application to physicochemical and biochemical processes, Chem. Soc. Rev. 22, 73-83 (1993).
38. Stewart, B. H., Chan, O. H., Jezyk, N., and Fleisher, D., Discrimination between drug candidates using models for evaluation of intestinal absorption, Adv. Drug Del. Rev. 23, 27-45 (1997).
39. Sharom, F. J., Liu, R., Romsicki, Y., and Lu, P., Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies, Biochim. Biophys. Acta 1461, 327-345 (1999).
40. Seelig, A., and Landwojtowicz, E., Structure-activity relationship of P-glycoprotein substrates and modifiers, Eur. J. Pharm. Sci. 12, 31-40 (1999).
41. Osterberg, T., Norinder, U., Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics, Eur. J. Pharm. Sci. 10, 295-303 (2000).
42. th edition, McGraw-Hill, New York 2001, p 55.
43. Chiou, W. L., and Barve, A., Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats, Pharm. Res. 15, 1792-1795 (1998).
44. Kansy, M., Senner, F., and Gubernator, K., Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes, J. Med. Chem. 41, 1007-1010 (1998).